Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
Abstract After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to participants and other stakeholders had to change. Instead of face-face events, three online events were planned and hosted successfully. In this article, we describe the choice...
Main Authors: | Hanne Bruhn, Annie S. Anderson, Amy Hickman, E. Jane Macaskill, Shaun Treweek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-021-05340-3 |
Similar Items
-
Providing trial results to participants in phase III pragmatic effectiveness RCTs: a scoping review
by: Hanne Bruhn, et al.
Published: (2021-05-01) -
Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
by: Raftery James, et al.
Published: (2012-08-01) -
Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
by: Anna Roberto, et al.
Published: (2018-04-01) -
Letter on Predicting the number of sites needed to deliver a multicentre clinical trial within a limited time frame in the UK
by: Rosemary Greenwood, et al.
Published: (2020-10-01) -
What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK
by: Lelia Duley, et al.
Published: (2018-01-01)